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Cyclosporine induces different responses in human epithelial, Long-term treatment with cyclosporine (CsA) has led
endothelial and fibroblast cell cultures. to the recognition of some major and limiting side effects
Background. Nephrotoxicity, accelerated atherosclerosis, such as nephrotoxicity [1–3] and accelerated athero-and graft vascular disease are common complications of cy-
sclerosis [4]. Nephrotoxicity is mainly characterized byclosporine long-term treatment characterized by a wide disrup-
interstitial fibrosis and tubular atrophy [5], but glomeru-tion of organ architecture with increased interstitial areas and
accumulation of extracellular matrix (ECM). How cyclosporine losclerosis has also been described [6]. Myointimal prolif-
induces these changes is not clear, but it is conceivable that eration is the hallmark of the graft vascular disease asso-
they are the sum of changes induced at the cell level. ciated with CsA treatment; however, changes in theMethods. We studied the effects of cyclosporine on human
endothelial cells lining blood vessels are also prominentendothelial (HEC), epithelial (HK-2), and fibroblast (MRC5)
with increased tissue factor expression [7] and endothelincells. Cell proliferation was evaluated by cell counting, apopto-
sis and collagen production by enzyme-linked immunosorbent production [8]. Moreover, endothelial cell and smooth
assay, and nitric oxide by measuring the concentration of ni- muscle cell both concur to the deposition of matrix and
trite/nitrate in the cell supernatant. (a1)I and (a2)IV collagen, therefore to the pathogenesis of vascular lesions [9].matrix metalloprotease-9 (MMP9), and tissue inhibitors of
Although it has been suggested that the accumulationmetalloprotease-1 (TIMP-1) mRNA levels were measured by
of extracellular matrix (ECM) may be a secondary effectreverse transcription-polymerase chain reaction. Proteolytic
activity was evaluated by zymography. of CsA-induced organ hypoperfusion [10], the mecha-
Results. Cyclosporine showed a marked antiproliferative nisms underlying CsA-induced injury are not completely
and proapoptotic effect on endothelial and epithelial cells. Fi- clear. New evidence supports a direct effect of CsA onbroblast growth was not affected by cyclosporine. Nitric oxide
endothelial and parenchymal cells [11, 12]. The responsewas up-regulated by cyclosporine in epithelial cells and fibro-
of each particular tissue or organ to external stimuliblasts but not in endothelial cells. (a1)I and (a2)IV collagen
synthesis was increased in cyclosporine-treated endothelial and depends mainly on its characteristic cells and architec-
epithelial cells, respectively. Proteolytic activity was increased ture. Thus, renal vascular and tubulointerstitial changes
in endothelial and epithelial cells. TIMP-1 mRNA was up- as well as sclerosis of glomeruli and graft vascular diseaseregulated by cyclosporine in fibroblasts.
may represent the effect of phenotypic alterations in-Conclusions. Our results demonstrate that cyclosporine ex-
duced by CsA on cells of different compartments, suchhibits an antiproliferative effect on endothelial and epithelial
cells. This effect is associated with induction of apoptosis proba- as tubules, interstitium, and vessel wall. The aim of our
bly via nitric oxide up-regulation in epithelial cell cultures. study was to evaluate the in vitro effects of CsA on
Cyclosporine treatment induces ECM accumulation by increas- human fibroblasts, human microvascular endothelial cells,ing collagen synthesis in endothelial and epithelial cells and
and human renal epithelial cells on both cell proliferationreducing its degradation by up-regulating TIMP-1 expression
and ECM turnover.in fibroblasts. We conclude that cyclosporine affects cell types
differently and that the disruption of organ architecture is the
result of multiple effects at the cell level.
METHODS
MaterialsKey words: matrix turnover, apoptosis, cell proliferation, transplanta-
tion, nitric oxide. Cyclosporine was obtained from Sandoz Pharmaceuti-
cal (Milan, Italy). RPMI 1640 medium, minimal Eagle’sReceived for publication June 21, 1999
medium (MEM), fetal calf serum (FCS), trypsin, penicil-and in revised form December 23, 1999
Accepted for publication January 21, 2000 lin, and streptomycin were supplied by Sigma-Aldrich
(Milan, Italy). Agarose and loading buffer were obtainedÓ 2000 by the International Society of Nephrology
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from FAPA Pharmaceutical (Pavia, Italy). Precast gels streptavidin-coated plates. After an extensive washing
to remove unbound material, the amount of nucleosomesfor zymography were from BioRad (Milan, Italy).
was quantitated by the peroxidase retained in the immu-
Antibodies nocomplex. Peroxidase was determined photometrically
after adding 2,29 -Azino-di[3-ethylbenzthiazolin-sulfo-Rabbit antihuman factor VIII and rabbit antihuman
cytokeratin were from Dako (Milan, Italy). Rabbit anti- nat] as substrate. The apoptosis was also quantitated by
flow cytometry using propidium iodide as described byhuman type I and IV collagen antibodies were kindly
donated by Dr. Liliane Striker (University of Miami, Nicoletti et al [14]. Briefly, cells were washed with PBS
and fixed in 70% alcohol. After a 30-minute incubationMiami, FL, USA). TRITC-labeled phalloidin was from
Sigma (Milan, Italy). with propidium iodide (40 mL/mL), cells were analyzed
by flow cytometry using a Becton Dickinson FACScan.
Cell and culture conditions
Nitric oxide assayHuman renal tubular epithelial cells (HK-2) and hu-
man skin fibroblasts (MRC-5) were obtained from Since nitric oxide (NO) is rapidly converted to its
metabolites, we measured its more stable products, ni-American Type Culture Collection (Rockville, MD,
USA) and were cultured, respectively, in keratinocyte trite/nitrate, using a two-step chromogenic assay. Briefly,
subconfluent HK-2 and HECs were incubated withmedium enriched with keratinocyte supplement and in
MEM supplemented with FCS (10%). Human microvas- MEM containing CsA (800 ng/mL). After 24 hours of
incubation, supernatant was collected, and cells werecular cells (HECs, human endothelial cells) were ob-
tained from human skin after collagenase (0.1%) diges- detached and counted. The assay was performed in 96-
well plates by adding assay buffer, supernatant (100 mL),tion. Endothelial cells were characterized by their
positivity for anti-factor VIII and antithrombomodulin and nitrate reductase-containing solution (50 mL) to con-
vert nitrate to nitrite. Plates were incubated two hoursantibodies and by their negativity for anticytokeratin
antibodies. Also, cell morphology and the arrangement at room temperature, and Griess reagents (100 mL) were
then added to each well to transform nitrite into a deepof F-actin filaments stained with phalloidin were used to
differentiate endothelial cells from smooth muscle cells blue azo compound [15]. The concentration of nitrite
was determined by comparison with a standard curveand fibroblasts [13]. HECs were cultured in RPMI sup-
plemented with FCS (10%). They were passaged using made in the presence of known amount of nitrite/nitrate.
trypsin-ethylenediaminetetraacetic acid (EDTA) solu-
Extracellular matrix turnovertion and were used at passages 7 through 13.
To study the ECM turnover, a1(I) and a2(IV) collagen
Cell proliferation subchains, 92 kD metalloprotease (MMP9), and tissue
inhibitor of metalloprotease-1 (TIMP-1) mRNA levelsExperiments were carried out adding CsA at a dose
of 800 ng/mL or at scalar doses (50, 200, 400, and 800 were measured with a method that combines in situ re-
verse transcriptase (RT) to polymerase chain reactionng/mL) to subconfluent cells cultured in 24-well plates.
Nontreated cells were used as control. After 24 hours (PCR) [16]. b-Actin was used as the housekeeping gene.
The PCR products were separated on a 4% agarose gel,of incubation for the dose dependence and after variable
intervals of time for the time-course experiments (24, 48, visualized with ethidium bromide, and quantitated by an
image analyzer (Fluor S; BioRad).and 72 hours), cells were counted using a NeuBauer cham-
ber. Cell viability was assessed by trypan blue exclusion.
Zymography for the metalloproteases
Apoptosis Cells were grown as previously described. When sub-
confluent, they were treated with CsA (800 ng/mL), andSubconfluent cells were treated with CsA (800 ng/mL)
for 24 hours, washed with phosphate-buffered saline after 24 hours, they were further incubated in serum-free
media containing 0.1% bovine serum albumin (BSA) for(PBS), and lysated in lysis buffer. The amount of cyto-
plasmic mononucleosomes and oligonucleosomes was 24 hours. The supernatant was collected, and the cells
were counted. The medium was concentrated 10 timesdetermined by enzyme-linked immunosorbent assay
(ELISA) using a cell death detection ELISA kit (Boeh- using a 22 kD cut-off filter (Millipore, Milan, USA). An
aliquot (32 mL) was loaded onto a 10% gelatin polyacryl-ringer Mannheim, Mannheim, Germany). Briefly, 20 mL
of cell lysate, corresponding to 1 3 103 cells, were placed amide gel (BioRad). After electrophoresis, the gel was
incubated in 2.5% Triton X-100 buffer for one hour atinto a streptavidin-coated microtiter plate. Subsequently,
antihistone-biotin and peroxidase-conjugated anti-DNA room temperature and then activated in development
buffer for 24 hours at 378C, as recommended by the manu-antibodies were added and incubated for two hours. The
antihistone antibody binds to the histone component of facturer. Gelatinase activity was visualized by staining
the gel with Coomassie brilliant blue. Matrix metallopro-the nucleosomes and fixes the immunocomplex to the
Esposito et al: CsA effects on different cell types 125
Fig. 1. Dose-dependent effect of cyclosporine on human endothelial
(HEC; h) and human epithelial (HK-2; j) cell growth. Cells were Fig. 2. Time-dependent effect of cyclosporine on HEC and HK-2 cell
plated in a 24-well plate (5 3 104 cell/well) and allowed to attach. Fresh growth. Cells were plated in a 24-well plate (5 3 104 cells/well) and
medium containing the indicated amounts of cyclosporine was added allowed to attach. Fresh medium containing cyclosporine (800 ng/mL)
for 24 hours. At the end of the incubation time, cells were counted. was added, and cells were counted at the indicated times. Untreated
The results are expressed as means 6 SD. **P , 0.01 vs. cyclosporine HEC and HK-2 were used as controls. Symbols are: (h) untreated and
0 ng/mL; ***P , 0.001 vs. cyclosporine 0 ng/mL. treated (j) HEC; (n) untreated and (m) treated HK-2. The results
are expressed as means 6 SD. *P , 0.05; **P , 0.01; ***P , 0.001
vs. untreated cells.
teases (MMP) levels were quantitated by an image ana-
lyzer.
in cell proliferation after 24 hours of incubation with
CsA when the cells were compared with untreated cells.ELISA for collagen types I and IV
Although HECs showed a significant reduction in cellNinety-six–well plates were coated with 150 mL of
growth at a CsA concentration of 200 ng/mL (3.0 3conditioned medium. After an overnight incubation,
104 6 2.9 3 103 vs. 6.1 3 104 6 6.6 3 103 cells, CsA andwells were washed with PBS/0.05% Tween-20 and
control, respectively, P , 0.01), the effect of CsA on cellblocked for 24 hours at 48C with PBS/2% BSA. Wells
growth was more striking on HK-2 cells, which showed awere incubated with 50 mL of rabbit antihuman type I
decline of cell number even at a lower concentration (50or type IV collagen antibody (1:1000) for 1.5 hours. Wells
ng/mL) of CsA (2.3 3 104 6 3.7 3 103 vs. 4.5 3 104 6were washed with PBS and incubated with biotin-conju-
3.3 3 103 cells, CsA and control, respectively, P , 0.001).gated goat antirabbit IgG antibody (1:5000 and 1:1000
Human fibroblast cell growth was not affected by CsAfor type IV and type I, respectively) in PBS/Tween-20 for
at the concentration of 800 ng/mL (5.4 3 104 6 4 3one hour. Alkaline phosphatase-conjugated streptavidin
103 vs. 5.8 3 104 6 0.8 3 103 cells, CsA and control,(1:5000) was added for one hour followed by 1 mg/mL
respectively, P 5 NS). The antiproliferative effect ofp-nitrophenyl phosphate for 30 minutes. Optical density
CsA on epithelial and endothelial cells was also timewas assessed at 405 nm using a Multiskan MCC/340 plate
dependent, reaching a maximum at 72 hours for thereader.
endothelial cells and at 48 hours for the epithelial cells
Statistical analysis (Fig. 2).
Each experiment was performed twice in duplicate or
Pro-apoptotic effect of CsA on endothelial andtriplicate wells. Data are expressed as mean 6 SEM.
epithelial cellsTwo-tailed unpaired Student’s t-test or one-way analysis
Next, we examined whether the antiproliferative effectof variance (ANOVA) were used to measure differences
of CsA occurred by the induction of apoptosis. Treat-between CsA-treated and control cells. P , 0.05 was
ment of subconfluent endothelial and epithelial cells withconsidered statistically significant.
CsA (800 ng/mL) for 24 hours induced a 2- and 3.5-fold
increase in the percentage of apoptotic cells, respectively
RESULTS (Fig. 3A). CsA did not up-regulate apoptosis in fibroblast
Effect of CsA on cell proliferation cultures (data not shown). The results obtained by
ELISA were confirmed by the flow cytometry study,Figure 1 shows the effect of different concentrations
of CsA on HEC and HK-2 cultures. There was a decrease which showed a 20 and 30% increase of apoptotic cells,
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Fig. 4. Nitrite accumulation in the supernatants of fibroblasts ( ),
HEC (h), and HK-2 (j) cell cultures treated with cyclosporine. Subcon-
fluent cells were incubated with cyclosporine (800 ng/mL) for 24 hours.
Media were harvested and assayed for nitrite concentration after nor-
malizing for cell number. *P , 0.05 vs. untreated cells.
1.5-fold in fibroblasts after CsA treatment. No difference
was observed in endothelial cells treated with CsA
(Fig. 4).
Modulation of extracellular matrix turnover by CsA
The effect of CsA on ECM turnover was then exam-
ined. CsA treatment did not modify the (a2)IV collagen
mRNA level in endothelial and epithelial cells (Fig. 5).
Although treated and untreated fibroblast cultures did
not express (a2)IV collagen mRNA, CsA treatment
slightly up-regulated fibroblasts (a1)I collagen mRNA
(data not shown). After CsA treatment, the release of
collagen type IV in the cell supernatant was significantlyFig. 3. Apoptosis in HEC (h) and HK-2 (j) cultures treated with
increased in HK-2 (7.69 6 1.5 vs. 12.1 6 0.45 ng/mL/105cyclosporine. (A) Subconfluent HEC and HK-2 were incubated with
cyclosporine (800 ng/mL) for 24 hours; 104 cells were lysated and centri- cells, P , 0.05) but not in the fibroblast and HEC cultures
fuged. Twenty microliters of supernatant were assayed for the presence
(Fig. 6). Collagen type I release was significantly in-of oligonucleosomal DNA using a cell death detection ELISA kit. The
results are expressed as arbitrary units per 103 cells. **P , 0.01 vs. creased in endothelial cells (2.23 6 0.8 vs. 3.89 6 0.6 ng/
untreated cells. (B) Subconfluent HEC and HK-2 were incubated with mL/105 cells, P , 0.01), decreased in epithelial cells
cyclosporine (800 ng/mL) for 24 hours. Cells were washed, fixed in 70%
(5.43 6 0.6 vs. 3.09 6 0.4 ng/mL/105 cells, P , 0.02) andalcohol, incubated with propidium iodide for 30 minutes, and analyzed
by flow cytometry. Results are expressed as the percentage of apoptotic not modified in fibroblasts (Fig. 7). These results led us
cells. **P , 0.05 vs. untreated cells. to consider the effect of CsA on ECM degradation. The
MMP9 mRNA level was not modified by CsA in endo-
thelial and epithelial cells (Fig. 5). MMP9 mRNA could
not be detected in treated and untreated fibroblasts. CsArespectively, in endothelial and epithelial cultures
treatment induced an increase of collagenolytic activitytreated with CsA (Fig. 3B).
in endothelial and HK-2 cells (18 and 100%, respectively,
Effect of CsA on NO synthesis of baseline values; Fig. 8). Endothelial and epithelial
cells demonstrated a different pattern of collagenolyticNitric oxide is an important intercellular messenger
activity, with HEC expressing only MMP2 and HK-2in a variety of pathological conditions. Since NO exhibits
expressing both MMP2 and MMP9 (Fig. 9). Fibroblasta well-defined antiproliferative effect [17] and its en-
collagenase activity was not modified by CsA. Finally,hanced expression has been correlated with the induction
there was a marked up-regulation of TIMP-1 mRNAof apoptosis [18], we measured its concentration in the
level in fibroblasts and HK-2 treated with CsA but notsupernatant of cells treated with CsA. The nitrite concen-
tration was threefold increased in epithelial cells and in HECs (Fig. 5).
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Fig. 5. Effect of cyclosporine on the expression of a2(IV) collagen, MMP9, TIMP-1 and b-actin mRNA levels in HEC, HK-2, and fibroblasts.
Cells were treated with cyclosporine (800 ng/mL) for 24 hours, and the mRNA levels were analyzed by RT-PCR, as described in the Methods
section.
is still undefined. We reasoned that the histopathological
changes are the net effect of multiple cellular alterations
induced by CsA on different cell types, which are repre-
sented in the target organs. To dissect the global effect
into its individual components and to better understand
the pathogenesis of CsA toxicity, we evaluated the ef-
fects of CsA on three cell types involved in CsA-induced
lesions that are epithelial and endothelial cells and fi-
broblasts. CsA reduced cell growth in epithelial and en-
dothelial cultures, whereas at the same concentration,
it did not exhibit an antiproliferative effect on human
fibroblasts. The differences in the growth curve after
CsA treatment observed in epithelial cells and fibroblasts
may explain the marked reduction and atrophy of tubu-
Fig. 6. Effect of cyclosporine on type IV collagen release in fibroblast lar epithelial cells and the expansion of interstitium re-( ), HEC (h), and HK-2 (j) cell cultures. Subconfluent cells were
ported in humans and in experimental animals treatedincubated with cyclosporine (800 ng/mL) for 24 hours. Media were
then changed with media containing 0.1% FCS and cyclosporine for with CsA [1, 19]. Our results showed that the effect of
24 hours. Cells were counted, and media were harvested and assayed CsA on cell growth was dependent on the length andfor type IV collagen after normalizing for cell number. *P , 0.05.
the dosage of CsA treatment, confirming the conclusions
of previous studies in vitro [12] and in humans (abstract;
Esposito et al, J Am Soc Nephrol 8:712A, 1997) [20],
DISCUSSION demonstrating that a higher concentration and a longer
treatment with CsA are associated with greater changes.Cyclosporine induces tubulointerstitial fibrosis and
Although the different modulation of cell growth in-glomerulosclerosis [6] and accelerates vascular graft dis-
duced by CsA in the three cell types used in the presentease [4]. Although these pathological changes have been
extensively described, the mechanism(s) underlying them study may sound surprising, different responses to CsA
Esposito et al: CsA effects on different cell types128
Fig. 8. Effect of cyclosporine on collagenolytic activity of fibroblasts,
Fig. 7. Effect of cyclosporine on type I collagen release in fibroblasts HEC, and HK-2 cultures. Subconfluents cells were incubated with
( ), HEC (h), HK-2 (j) cell cultures. Subconfluent cells were incu- cyclosporine (800 ng/mL) for 24 hours. Media were then changed to
bated with cyclosporine (800 ng/mL) for 24 hours. Media were then media containing 0.1% FCS and cyclosporine for a further 24 hours.
changed to media containing 0.1% FCS and cyclosporine for 24 hours. Cells were counted, and media were diluted to normalize for cell
Cells were counted, and media were harvested and assayed for type number, concentrated with a Centricon system, loaded onto a gelatin
I collagen after normalizing for cell number. *P , 0.05. gel and run. The bands on the zymogram were measured by densitome-
try. The percentage of total collagenolytic activity is shown. One hun-
dred percent is the baseline value. Symbols are: (h) untreated cells,
(j) treated cells. *P , 0.05 vs. control.
have been reported previously, with some reports show-
ing an enhanced proliferation [21–23] and others an in-
hibitory effect on cell growth [24]. Since in our study all the cell response to extracellular mediators; however,
cell types were treated with the same concentration of further experiments with antagonists and agonists of NO
are needed to demonstrate the relationship between NOCsA by the same operators, it is conceivable that the
and apoptosis. We have not investigated the mechanismsdifferent responses to CsA depended on the cell type.
leading to the increased synthesis of NO in our cells.Apoptosis is one of the major mechanisms regulating
However, others have shown an increase in the bindingcell growth. This process of programmed cell death has
of the transcription factor, activated protein-1 (AP-1),been indicated as the possible mechanism contributing
in the NO synthase promoter after treatment with CsAto the loss of cell and tubulointerstitial fibrosis in CsA-
[29]. Our results are apparently in contrast with previousinduced nephrotoxicity [25]. We found that the delay in
in vivo studies demonstrating a reduction of NO in ratshuman epithelial and endothelial cell growth was associ-
after treatment with CsA [25, 30]. These studies sug-ated with CsA-induced apoptosis, confirming previous
gested a role for NO down-regulation in the pathogenesisdata from Ortiz et al, who showed that CsA could induce
of CsA-induced hypertension and in the induction ofapoptosis in murine tubular epithelial cells with a mecha-
apoptosis, which may favor CsA-associated interstitialnism involving caspases 8, 9, and 3 [26]. Healy et al
fibrosis. In vivo studies, however, measure the net pro-
demonstrated that the induction of apoptosis by CsA is
duction of NO, and thus, they are not able to discriminate
dose related [27]. Since we observed a more sustained the contribution of each cell type, which may be up- or
effect on epithelial cells, it is possible that endothelial down-regulated by CsA. Since this study examined the
cells were less sensitive to CsA than epithelial cells at effect of CsA on NO production, we cannot exclude a
the concentrations we have used in the present study. role of other potential mediators in CsA-induced apo-
Nitric oxide has been shown to have an antiprolifera- ptosis. For example, Ortiz et al demonstrated that CsA
tive effect mediated by the induction of apoptosis increased the expression of the FAS receptor in murine
[18, 28]. An up-regulation of NO synthesis paralleled proximal tubular epithelial cells [26]. Furthermore, CsA
the induction of apoptosis in epithelial cell cultures has been shown to increase the mRNA expression of
treated with CsA, suggesting that NO may play a role transforming growth factor-b, a cytokine known to act
in CsA-induced apoptosis. NO synthesis was also in- as a mediator of apoptosis [19]. Finally, the changes
creased in fibroblasts but not in endothelial cells. The induced by CsA in ECM composition, observed in our
lack of apoptosis in fibroblasts in presence of an in- study and other studies may function as a pro-apoptotic
signal.creased production of NO confirms the differences in
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Fig. 9. Zymography of conditioned medium
from HEC and HK-2 cultures treated with
cyclosporine (800 ng/mL). Untreated HEC
and HK-2 cells were used as the controls. The
upper lane represents MMP9, and the lower
lane represents MMP2. Molecular weight is
shown on the right.
Extracellular matrix accumulation is the hallmark of with CsA [36]. Furthermore, the cells responsible for
the increased TIMP-1 message transcription were mainlysclerotic processes that affect vessel wall, tubulointersti-
tium, or glomeruli [31, 32]. Matrix turnover is a finely interstitial cells. We restricted our study to the evaluation
of collagen I and collagen IV, which represent two of theregulated process. In physiologic conditions, there is a
dynamic balance between synthesis and degradation of most common matrix proteins in fibrosis and basement
membrane, and of MMP2 and MMP9, which are impli-ECM components. MMPs are the enzymes that degrade
collagen and other matrix proteins in order to remodel cated in physiological and pathological processes related
to matrix turnover. However, the network that regulatesbasement membranes and interstitial matrix. MMP-
mediated degradation is regulated by specific inhibitors matrix remodeling is very complicated and difficult to
unravel in one study. Based on our results, we can onlycalled TIMPs [33]. Several cell types are involved in
the processes of basement membrane remodeling and speculate that CsA may also modulate in profibrotic
manner other matrix proteins or collagenases not investi-interstitial matrix turnover. However, their contribution
may vary, especially in pathological conditions since cells gated in the present study.
In conclusion, CsA affects endothelial cell, epithelialare affected differently by environmental stimuli. In the
current study, we demonstrated that CsA treatment in- cell, and fibroblast inducing changes in cell proliferation,
NO production, and ECM turnover, with every cell typeduced a significant increase of collagen type IV in super-
natants of epithelial cells but not in endothelial cells. showing a different response. The understanding of these
multiple cellular effects is important in order to elucidateThis increase of collagen type IV synthesis was not paral-
the pathogenesis of CsA’s side-effects and ultimatelyleled by an increased a2(IV) collagen mRNA level, sug-
conceive future therapeutic interventions.gesting either a change in translational regulation or a
down-regulation of the degradative pathway by CsA.
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